Breast cancer angiogenesis and tamoxifen resistance

Endocrine-Related Cancer

Volumn 2, Issue 1, 1995, Pages 97-103

  Macaulay, V M ^a   Fox, S B ^b   Zhang, H ^c   Whitehouse, R M ^a   Leek, R D ^b   Gatter, K C ^b   Bicknell, R ^c   Harris, A L ^a,c  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; COMPLICATION; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE;

EID: 0028941746     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0020097     Document Type: Article

References (38)

1. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM & Osborne CK 1992 Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Research and Treatment 24 85-95.
2. Borg A, Baldetorp B, Ferno M, Killander D, Olsson H, Ryden S & Sigurdsson H 1994 ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer. Cancer Letters 81 137-144.
3. Bosari S, Lee A, DeLellis R, Wiley B, Heatley G & Silverman M 1992 Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathology 23 755-761.
4. Cullen KJ, Allison A, Martire I, Ellis M & Singer C 1992 Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Research and Treatment 22 21-29.
5. Dotzlaw H, Alkhalaf M & Murphy LC 1992 Characterization of estrogen receptor variant mRNAs from human breast cancers. Molecular Endocrinology 6 773-785.
6. Elston C 1987 Grading of invasive carcinoma of the breast. In Diagnostic Histopathology of the Breast, pp 300-311. Eds D Page & T Anderson. Edinburgh: Churchill Livingstone.
7. Faust JB & Meeker TC 1992 Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Research 52 2460-2463.
8. Folkman J 1990 What is the evidence that tumours are angiogenesis dependent? Journal of the National Cancer Institute 82 4-6.
9. Foster BD, Cavener DR & Pari FF 1991 Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer. Cancer Research 51 3405-3410.
10. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M & Harris AL 1994 Tumor angiogenesis in node-negative breast carcinomas - relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Research and Treatment 29 109-116.
11. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW & McGuire WL 1991 Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Research 51 105-109.
12. Gagliardi A & Collins DC 1993 Inhibition of angiogenesis by antioestrogens. Cancer Research 53 533-535.
13. Harris AL, Fox S, Bicknell R, Leek R, Relf M, Lejeune S & Kaklamanis L 1994 Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer 74 1021-1025.
14. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K & Harris AL 1992 Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340 1120-1124.
15. Horwitz KB 1993 Mechanisms of hormone resistance in breast cancer. Breast Cancer Research and Treatment 26 119-130.
16. Johnston SRD, Haynes BP, Smith IE, Jarman M, Sacks NPM, Ebbs SR & Dowsett M 1993 Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration. Lancet 342 1521-1522.
17. H DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. Science 228 725-728.
18. Katzenellenbogen BS, Bhardwaj B, Fang H, Ince BA, Pakdel F, Reese JC, Schodin D & Wrenn CK 1993 Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. Journal of Steroid Biochemistry and Molecular Biology 47 39-48.
19. Keen JC, Miller EP, Bellamy C, Dixon JM & Miller WR 1994 P-glycoprotein and resistance to tamoxifen. Lancet 343 1047-1048.
20. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB & Kern FG 1993 Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Research 53 2178-2187.
21. Liotta LA & Steuer-Stevenson WG 1991 Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Research (Suppl) 51 5054s-5059s.
22. Lippman ME & Dickson RB 1990 Progress in Clinical and Biological Research 354A 147-178.
23. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB & Kern FG 1993 Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Research 53 2168-2177.
24. Morris PB, Hida T, Blackshear PJ, Klintworth GK & Swain JL 1988 Tumor promoting phorbol esters induce angiogenesis in vivo. American Journal of Physiology 254 C315-C322.
25. Needham GK, Nicholson S, Angus B, Farndon JR & Harris AL 1988 Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors. Cancer Research 48 6603-6607.
26. Nicholson S, Sainsbury JRC, Halcrow P, Kelly P, Chambers P, Farndon JR & Harris AL 1989 Epidermal growth factor receptor expression is associated with lack of response to endocrine therapy in patients with recurrent breast cancer. Lancet i 182-185.
27. Normanno N, Ciardiello F, Brandt R & Salomon DS 1994 Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Research and Treatment 29 11-27.
28. Osborne CK 1993 Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism. Journal of Steroid Biochemistry and Molecular Biology 46 83-89.
29. Parums D, Cordell J, Micklem K, Heryet A, Gatter K & Mason D 1990 JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. Journal of Clinical Pathology 43 752-757.
30. Scott GK, Kushner P, Vigne J-L & Benz CC 1991 Truncated forms of DNA-binding estrogen receptors in breast cancer. Journal of Clinical Investigation 88 700-706.
31. Shiu RP, Watson PH & Dubik D 1993 C-myc oncogene expression in estrogen-dependent and -independent breast cancer. Clinical Chemistry 39 353-355.
32. Shweiki D, Itin A, Neufeld G, Gitaygoren H & Keshet E 1993 Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally-regulated angiogenesis. Journal of Clinical Investigation 91 2235-2243.
33. Silvestrini R, Benini E, Daidone M, Veneroni S, Boracchi P, Capelletti V, di Fronzo G & Veronesi U 1993 p53 as an independent prognostic marker in node negative breast cancer patients. Journal of the National Cancer Institute 85 965-970.
34. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F & Veronesi U 1994 The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph-node negative breast cancer patients. Journal of the National Cancer Institute 86 499-504.
35. Toi M, Kashitani J & Tominaga T 1993 Tumor angiogenesis is an important prognostic indicator in primary breast cancer. International Journal of Cancer 55 371-374.
36. Van Hoef ME, Knox WF, Dhesi SS, Howell A & Schor AM 1993 Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. European Journal of Cancer 29A 1141-1145.
37. Visscher DW, Smilanetz S, Drozdowicz S & Wykes SM 1993 Prognostic significance of image microvessel enumeration in breast carcinoma. Analytical Quantitative Cytology and Histology 15 88-92.
38. Weidner N, Semple JP, Welch WR & Folkman J 1991 Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine 324 1-8.